Mortality from Acute Bronchiolitis in Infants under 1 Year of Age between 2014 and 2024 in Brazil: An Ecological Time Series Study

Authors

DOI:

https://doi.org/10.36557/2674-8169.2026v8n2p974-988

Keywords:

Infant Mortality, Bronchiolitis, Respiratory Syncytial Virus, Human, Brazil

Abstract

ABSTRACT

Introduction: Acute bronchiolitis is the leading cause of hospitalization and death due to respiratory infection in children under one year of age. Recently, the epidemiological profile of the disease has been drastically altered by the "immunity debt" phenomenon following the COVID-19 pandemic, making the monitoring of mortality indicators in the country essential.

Objectives: To analyze the magnitude and trend of mortality from acute bronchiolitis in children under one year of age in Brazil (2014-2024), characterizing temporal dynamics and sociodemographic profiles to support public policies and the improvement of pediatric care.

Methodology: A quantitative cross-sectional study based on secondary data from the Department of Informatics of the Unified Health System (Mortality Information System and Live Birth Information System). Deaths (ICD-10: J21) were analyzed by year, region, age group, sex, and ethnicity. Specific mortality rates and proportional mortality were calculated and systematized using electronic spreadsheets.

Results: A total of 2,855 deaths were recorded. The trajectory was upward until 2019 (244), followed by a decline in 2020 (68). The final biennium showed a sharp surge, peaking in 2023 (577 deaths; 20.2%) and remaining high in 2024 (537). The national rate in 2023 (0.227/1,000 live births) was four times higher than in 2014, a fact associated with the post-pandemic "immunity debt." The Southeast region held the highest absolute burden (46.5%), while the Northeast (0.296) and Midwest (0.261) presented the highest epidemiological risks in 2023. Mortality was concentrated among infants aged 28-364 days (96.7%), males (57.7%), and White (46.0%) and Pardo (42.1%) ethnicities. Proportional mortality reached 1.80% in 2023, consolidating the pathology as a critical cause of death.

Conclusion: Bronchiolitis has consolidated as a growing threat to infants. The worsening indicators highlight healthcare vulnerabilities and regional inequalities. It is imperative to advance the decentralization of intensive care beds and the implementation of new preventive technologies, such as long-acting monoclonal antibodies, aiming to reduce preventable infant mortality in the country.

 

Downloads

Download data is not yet available.

References

Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, et al. Immunity debt: Prospective implications for children’s health of COVID-19 non-pharmaceutical interventions. Infect Dis Now. 2021;51(5):418-23.

Brasil. Ministério da Saúde. Boletim Epidemiológico SIVEP-Gripe: Vigilância de Síndrome Respiratória Aguda Grave (SRAG). Brasília: Ministério da Saúde; 2023.

Fundação Oswaldo Cruz. Internações de bebês no SUS por problemas respiratórios bateram recorde em 2023. Rio de Janeiro: Fiocruz; 2024.

Silva LS, Salim TR. O comportamento da bronquiolite durante a pandemia de COVID-19: impactos causados no Brasil. Rev Saude. 2023;14(1):12-20.

Dos Santos DS, et al. Morbiletalidade por bronquite e bronquiolite aguda em crianças menores de um ano: estudo nacional de série histórica, 2013-2022. Res Soc Dev. 2023;12(9):e13212943144.

Sociedade Brasileira de Pediatria. Documento Científico: Vírus Sincicial Respiratório (VSR). São Paulo: SBP; 2023.

Castro MC, Kim S, Barberia L, Ribeiro AF, Gurzenda S, Ribeiro KB, et al. Spatiotemporal pattern of COVID-19 spread in Brazil. Science. 2021;372(6544):821-26.

Sociedade Brasileira de Pediatria. Manual de Orientação: Vigilância Epidemiológica das Infecções Respiratórias Agudas. São Paulo: SBP; 2024.

Fundação Oswaldo Cruz. ObservaInfância: Boletim de Monitoramento da Saúde Infantil. Rio de Janeiro: Fiocruz; 2024.

Teper A, Fischer GB. Sex-related differences in lung development and disease. Am J Respir Crit Care Med. 2021;203(10):1218-25.

Werneck J. Racismo institucional e saúde da população negra. Saude Soc. 2022;31(1):e220000.

Pires R, et al. Iniquidades sociais e mortalidade infantil por causas evitáveis no Brasil. Rev Saude Publica. 2024;58:15.

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22.

Safadi MA, et al. Prevention of Respiratory Syncytial Virus Infection in Brazil: Challenges and New Perspectives. J Pediatr (Rio J). 2024;100(2):145-52.

Sociedade Brasileira de Imunizações. Novas vacinas e anticorpos monoclonais contra o VSR: nota técnica. São Paulo: SBIm; 2024.

Published

2026-02-19

How to Cite

Dutra , T. A., & Trindade , M. L. da. (2026). Mortality from Acute Bronchiolitis in Infants under 1 Year of Age between 2014 and 2024 in Brazil: An Ecological Time Series Study. Brazilian Journal of Implantology and Health Sciences, 8(2), 974–988. https://doi.org/10.36557/2674-8169.2026v8n2p974-988